Evonik Aktie
WKN DE: EVNK01 / ISIN: DE000EVNK013
|
11.03.2024 11:20:05
|
EQS-CMS: Dissemination of a Post-admission Duties announcement
|
EQS Post-admission Duties announcement: Evonik Industries AG
/ Disclosure according to Art. 5(1) lit. b) of the Regulation (EU) No. 596/2014 and Art. 2(3) of the Delegated Regulation (EU) No. 2016/1052 - Purchase of own shares to be offered in the course of an employee share purchase program
Evonik Industries AG / Disclosure according to Art. 5(1) lit. b) of the Regulation (EU) No. 596/2014 and Art. 2(3) of the Delegated Regulation (EU) No. 2016/1052 - Purchase of own shares to be offered in the course of an employee share purchase program In the time period from 06 March 2024 until and including 08 March 2024, Evonik Industries AG has purchased a total number of 260,162 shares within the framework of the current share buy-back program, which has been disclosed pursuant to Art. 5(1) lit a) of the Regulation (EU) No. 596/2014 and Art. 2(1) of the Delegated Regulation (EU) No. 2016/1052 on 04 March 2024. The following quantities have been purchased:
The total volume of shares which have been purchased within the framework of the share buy-back program in the time period from 06 March 2024 until and including 08 March 2024 amounts to 260,162 shares. The buy-back of the shares of Evonik Industries AG is lead-managed by a bank which has been mandated by Evonik Industries AG and has been executed through the stock exchange on the electronic trading platform of the Frankfurt Stock Exchange (Xetra) exclusively. Detailed information on the transactions relating to the buy-back program is, in accordance with Art. 2(3) DR 2016/1052, published on the website of Evonik Industries AG: https://corporate.evonik.com/en/investor-relations/share/employee-share-program/. Essen, 11 March 2024 Evonik Industries AG The Executive Board
11.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Evonik Industries AG |
| Rellinghauser Straße 1-11 | |
| 45128 Essen | |
| Germany | |
| Internet: | www.evonik.com |
| End of News | EQS News Service |
|
|
1855525 11.03.2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Evonik AGmehr Nachrichten
|
18.12.25 |
MDAX-Handel aktuell: Zum Handelsende Pluszeichen im MDAX (finanzen.at) | |
|
18.12.25 |
EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, buy (EQS Group) | |
|
18.12.25 |
EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, Kauf (EQS Group) | |
|
17.12.25 |
MDAX-Papier Evonik-Aktie: So viel Verlust hätte eine Investition in Evonik von vor 5 Jahren bedeutet (finanzen.at) | |
|
17.12.25 |
Zurückhaltung in Frankfurt: MDAX präsentiert sich zum Start leichter (finanzen.at) | |
|
16.12.25 |
Verluste in Frankfurt: MDAX gibt am Nachmittag nach (finanzen.at) | |
|
11.12.25 |
Gewinne in Frankfurt: MDAX bewegt sich zum Ende des Donnerstagshandels im Plus (finanzen.at) | |
|
11.12.25 |
Europäische Chemieaktien kämpfen 2025 - Citigroup sieht BASF als Top Pick - LANXESS und Evonik als Verlierer (dpa-AFX) |
Analysen zu Evonik AGmehr Analysen
| 16.12.25 | Evonik Neutral | UBS AG | |
| 28.11.25 | Evonik Neutral | JP Morgan Chase & Co. | |
| 24.11.25 | Evonik Hold | Deutsche Bank AG | |
| 12.11.25 | Evonik Equal Weight | Barclays Capital | |
| 11.11.25 | Evonik Sell | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
| Evonik AG | 13,17 | -0,30% |
|